Responses
Regular and Young Investigator Award Abstracts
Novel Single-Agent Immunotherapies
1400 YF550-C1 promotes T cell activation, cytokines release and induces robust tumor growth inhibition in syngeneic and PDX tumor models
Compose a Response to This Article
Other responses
No responses have been published for this article.
